A

aesthetic-partners

lightning_bolt Market Research

Aesthetic Partners Company Profile



Background



Overview

Aesthetic Partners is a clinical aesthetics practice management firm specializing in high-end, physician-led, and patient-centric medical aesthetics, cosmetic dermatology, and plastic surgery practices across the United States. Founded in 2019 and headquartered in Miami, Florida, the company focuses on supporting the strategic growth of its partner practices by providing growth capital, operational expertise, and expansion support.

Mission and Vision

Aesthetic Partners' mission is to empower exceptional physician-led practices in the medical aesthetics and plastic surgery sectors by offering tailored support that enables them to maintain brand equity and foster customer loyalty. The company's vision is to create a collaborative network of top-tier practices, preserving the unique identities of its partners while driving growth and innovation.

Industry Significance

Since its inception, Aesthetic Partners has expanded its portfolio to include 20 practices across California, Florida, North Carolina, and Virginia. This growth underscores the company's significant role in the rapidly evolving medical aesthetics industry, which has seen increased consumer demand and investment interest.

Key Strategic Focus



Core Objectives

  • Expansion and Growth: Aesthetic Partners aims to expand its network by partnering with leading medical aesthetics and plastic surgery practices, providing them with the resources and support needed for growth.


  • Operational Excellence: The company focuses on enhancing operational efficiencies within its partner practices through centralized support in areas such as marketing, human resources, training, technology, and legal services.


  • Clinical Leadership: Emphasizing a "clinician-first" philosophy, Aesthetic Partners invests in robust clinical leadership to ensure high standards of patient care and clinical outcomes.


Areas of Specialization

  • Medical Aesthetics: Non-invasive treatments aimed at enhancing appearance and addressing aesthetic concerns.


  • Cosmetic Dermatology: Procedures focused on improving skin health and appearance.


  • Plastic Surgery: Surgical interventions for both reconstructive and aesthetic purposes.


Key Technologies Utilized

Aesthetic Partners leverages advanced medical technologies and treatment modalities to ensure its partner practices offer cutting-edge services to their patients. The company maintains relationships with key opinion leaders (KOLs) and top manufacturers to identify and integrate innovative technologies that enhance client experience and competitive advantage.

Primary Markets Targeted

The company primarily targets suburban markets across the United States, focusing on areas with growing demand for medical aesthetics and plastic surgery services. By partnering with established practices in these regions, Aesthetic Partners aims to expand its footprint and serve a broader patient base.

Financials and Funding



Funding History

Aesthetic Partners has secured funding to support its growth initiatives. In November 2023, the company announced a strategic partnership with global investment firm Norwest, which provided growth capital to accelerate expansion into new markets. This partnership also led to the addition of Norwest's Sonya Brown and Scott Mitchell to Aesthetic Partners' board of directors.

Total Funds Raised

Specific details regarding the total funds raised by Aesthetic Partners are not publicly disclosed.

Notable Investors

  • Norwest Venture Partners: A leading venture and growth equity investment firm that invested in Aesthetic Partners in November 2023.


Intended Utilization of Capital

The capital from the partnership with Norwest is intended to support infrastructure investments and expansion across existing and new clinics, enabling Aesthetic Partners to enhance its operational capabilities and accelerate growth in new markets.

Pipeline Development



As a practice management firm, Aesthetic Partners does not develop its own clinical pipeline but focuses on partnering with and supporting the growth of existing medical aesthetics and plastic surgery practices. The company's strategy involves identifying and integrating innovative technologies and treatment modalities into its partner practices to enhance service offerings and patient outcomes.

Technological Platform and Innovation



Proprietary Technologies

Aesthetic Partners does not develop proprietary technologies but collaborates with leading manufacturers and KOLs to integrate advanced medical technologies into its partner practices. This approach ensures that partner practices have access to the latest innovations in medical aesthetics and plastic surgery.

Significant Scientific Methods

The company emphasizes evidence-based practices and continuous professional development to ensure that its partner practices offer treatments grounded in the latest scientific research and clinical guidelines. This commitment to clinical excellence is supported by comprehensive training programs and a Medical Advisory Board comprising physicians from partner brands.

AI-Driven Capabilities

While specific AI-driven capabilities are not detailed, Aesthetic Partners' focus on operational excellence and business intelligence suggests the potential integration of data analytics and AI tools to optimize business performance and patient care.

Leadership Team



Key Executives

  • Courtney Ellenbogen: Co-founder and Co-CEO. Courtney co-founded Aesthetic Partners and serves as Co-CEO, focusing on strategic growth and partnerships.


  • Faraz Karbasi: Co-founder and Co-CEO. Faraz co-founded Aesthetic Partners and serves as Co-CEO, emphasizing the company's commitment to supporting founders and fostering growth.


  • Chanda Fulgium: Chief Operations Officer. Chanda oversees the company's operational strategies and ensures efficient execution of business plans.


  • Stephanie Swingle: Chief Marketing Officer. Stephanie leads marketing initiatives to enhance brand presence and support partner practices.


  • Crystal Winkler: Vice President of People Operations. Crystal manages human resources and talent development to foster a positive organizational culture.


  • Parker Prestegard: Head of De Novo Expansion. Parker is responsible for identifying and developing new practice locations to expand the company's footprint.


  • Jessica Blum: Controller and Senior Director of Strategic Finance. Jessica oversees financial operations and strategic financial planning.


  • Phillip Martinelli: Head of Corporate Development, Senior Director of Finance. Phillip leads corporate development initiatives and financial strategy.


  • Louis-Philippe Edger: Financial Planning & Analysis. Louis-Philippe manages financial planning and analysis to support business decisions.


  • Natalia Ilina: Senior Manager of Strategy, Growth, and Operations. Natalia drives strategic initiatives and operational growth.


  • Bailey Daniel: Senior Manager, Lifecycle Marketing. Bailey focuses on marketing strategies to enhance patient engagement and retention.


  • Sam Adams: Senior Manager of Design and Construction. Sam oversees the design and construction of new practice locations.


Leadership Changes

In August 2025, Aesthetic Partners expanded its clinical leadership team by promoting three distinguished medical leaders to new national roles:

  • John Wakelin, M.D., FACS: Elevated to Chief Medical Officer, overseeing clinical governance and safety protocols.


  • Jason Pozner, M.D.: Elevated to Chief Innovation Officer, leading the integration of next-generation technologies and treatments.


  • Jeff Birchall, M.D.: Elevated to Director of Scientific Education and Provider Development, advancing peer-to-peer education and development programs.


Competitor Profile



Market Insights and Dynamics

The medical aesthetics industry has experienced significant growth, driven by increased consumer demand for non-invasive and minimally invasive procedures. This growth has attracted substantial investment and led to consolidation within the sector. The U.S. medspa market was valued at over $18.0 billion in 2024 and is projected to reach $49.0 billion by 2030, growing at a 15% compound annual growth rate.
Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI